Arcutis Biotherapeutics, Inc. (ARQT) - Revenue and Sales Volume

Symbol and logo of brand Arcutis (ARQT)

Arcutis Biotherapeutics (ARQT) develops non-steroidal treatments for dermatitis and psoriasis. The GURU.Markets terminal displays the company's sales volume changes, where the 0.51 metric serves as the target level. The stable operation of partner plants guarantees the absence of product shortages. The integration of immunological knowledge with high-quality ointment textures forms a new ecosystem for daily skincare.

Arcutis Biotherapeutics (ARQT) - Revenue and Sales Volume from 07/04/2022 to 11/17/2026

Analytical breakdowns for Arcutis Biotherapeutics, Inc. (ARQT)

Summary company analysis:Arcutis Biotherapeutics
Core merchandise of arcutis.com

This indicator captures the aggregate cash inflow from product sales, reflecting the operational efficiency and market penetration of Arcutis Biotherapeutics (ARQT) in real time. The growth in the company's monthly sales confirms the successful commercialization of non-hormonal treatments for dermatitis and psoriasis, allowing investors to assess the scaling pace of the innovative therapy and the relevance of the Arcutis Biotherapeutics business strategy through this chart.